Skip to main content

Eduard Batlle: In ten years there will be a test that can predict recurrence in colon cancer

Contact

Image
Section Head of Communication & Outreach
Tel.+34 93 40 37255

The newspaper ABC, with a circulation of 342,820 copies, has interviewed Eduard Batlle, Coordinator of the Oncology Programme at IRB Barcelona, about colon cancer and how it develops from a benign tumour in the epithelial layers. The intestinal epithelium regenerates very quickly and therefore has very active stem cells that can, by mutations in their DNA, become cancerous. "The challenge is to identify cancer stem cells and distinguish them from healthy ones in order to design a more selective treatment," said Batlle.

About IRB Barcelona

The Institute for Research in Biomedicine (IRB Barcelona) pursues a society free of disease. To this end, it conducts multidisciplinary research of excellence to cure cancer and other diseases linked to ageing. It establishes technology transfer agreements with the pharmaceutical industry and major hospitals to bring research results closer to society, and organises a range of science outreach activities to engage the public in an open dialogue. IRB Barcelona is an international centre that hosts 400 researchers and more than 30 nationalities. Recognised as a Severo Ochoa Centre of Excellence since 2011, IRB Barcelona is a CERCA centre and member of the Barcelona Institute of Science and Technology (BIST).